$BURU
Nuburu, Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024097169 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $49.28K
YoY Change -100.0% -95.32%
Cost Of Revenue $360.0K $733.7K
YoY Change -67.74% -70.48%
Gross Profit -$360.0K -$684.4K
YoY Change -61.25% -52.18%
Gross Profit Margin -1388.95%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $206.5K $683.4K
YoY Change -84.69% -57.8%
% of Gross Profit
Depreciation & Amortization $206.7K $132.6K
YoY Change 42.61% 34.12%
% of Gross Profit
Operating Expenses $2.261M $2.721M
YoY Change -46.26% -45.68%
Operating Profit -$2.621M -$3.406M
YoY Change -48.98% -47.12%
Interest Expense $929.0K $941.6K
YoY Change 470.79% 7503.47%
% of Operating Profit
Other Income/Expense, Net $0.00 $218.2K
YoY Change -100.0% -34.72%
Pretax Income -$4.378M -$12.69M
YoY Change -13.92% 107.76%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.378M -$12.69M
YoY Change -13.92% 107.76%
Net Earnings / Revenue -25746.56%
Basic Earnings Per Share -$1.12 -$7.60
Diluted Earnings Per Share -$1.12 -$7.60
COMMON SHARES
Basic Shares Outstanding 3.273M 36.93M
Diluted Shares Outstanding 3.925M 1.670M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $232.1K $117.2K
Short-Term Investments
Other Short-Term Assets $4.464K $6.00
YoY Change -66.37% -99.92%
Inventory $1.526M $1.526M
Prepaid Expenses
Receivables $54.60K $73.28K
Other Receivables
Total Short-Term Assets $2.340M $2.612M
YoY Change -38.86% -69.6%
LONG-TERM ASSETS
Property, Plant & Equipment $5.137M $5.344M
YoY Change 7.85% 23.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $34.36K $34.36K
YoY Change 0.0% 0.0%
Total Long-Term Assets $5.472M $5.776M
YoY Change 3.89% 15.96%
TOTAL ASSETS
Total Short-Term Assets $2.340M $2.612M
Total Long-Term Assets $5.472M $5.776M
Total Assets $7.812M $8.387M
YoY Change -14.1% -38.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.962M $5.675M
YoY Change 42.48% 39.74%
Accrued Expenses $4.443M $4.317M
YoY Change 166.08% 172.41%
Deferred Revenue $24.00K $24.00K
YoY Change -89.57% -86.67%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.67M $13.50M
YoY Change 142.98% 118.33%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $15.67M $13.50M
Total Long-Term Liabilities
Total Liabilities $20.27M $19.34M
YoY Change 49.1% 42.32%
SHAREHOLDERS EQUITY
Retained Earnings -$120.1M -$100.3M
YoY Change 55.61% 39.16%
Common Stock $569.00 $325.00
YoY Change -83.99% -90.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$36.34M -$10.95M
YoY Change
Total Liabilities & Shareholders Equity $7.812M $8.387M
YoY Change -14.1% -38.2%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$4.378M -$12.69M
YoY Change -13.92% 107.76%
Depreciation, Depletion And Amortization $206.7K $132.6K
YoY Change 42.61% 34.12%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001814215
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39489
dei Entity Registrant Name
EntityRegistrantName
NUBURU, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1288435
dei Entity Address Address Line1
EntityAddressAddressLine1
7442 S Tucson Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 130
dei Entity Address City Or Town
EntityAddressCityOrTown
Centennial
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
767-1400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BURU
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3273388
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117188
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2148700
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
73275
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
482279
CY2024Q2 us-gaap Inventory Adjustments
InventoryAdjustments
1161469
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1133457
CY2024Q2 us-gaap Inventory Net
InventoryNet
1526402
CY2023Q4 us-gaap Inventory Net
InventoryNet
1456275
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
50000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
894679
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
156255
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2611544
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4293509
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5343753
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5650976
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
397388
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
586164
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34359
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34359
CY2024Q2 us-gaap Assets
Assets
8387044
CY2023Q4 us-gaap Assets
Assets
10565008
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5675344
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4744606
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4316645
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2750305
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
418162
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
355385
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30400
CY2024Q2 buru Shareholder Advance
ShareholderAdvance
644936
CY2024Q2 buru Note Payable Current
NotePayableCurrent
2423274
CY2023Q4 buru Note Payable Current
NotePayableCurrent
2147992
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13502361
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10028688
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
237369
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5385147
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
6713241
CY2024Q2 buru Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
452007
CY2023Q4 buru Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
2238519
CY2024Q2 us-gaap Liabilities
Liabilities
19339515
CY2023Q4 us-gaap Liabilities
Liabilities
19217817
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2388905
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2388905
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2388905
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2388905
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
239
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
239
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3247323
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3247323
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
922362
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
922362
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
325
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
92
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89333698
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73245552
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100286733
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81898692
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-10952471
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8652809
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8387044
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10565008
CY2024Q2 us-gaap Revenues
Revenues
49278
CY2023Q2 us-gaap Revenues
Revenues
1054062
us-gaap Revenues
Revenues
142827
us-gaap Revenues
Revenues
1524051
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
733726
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
2485264
us-gaap Cost Of Revenue
CostOfRevenue
1590682
us-gaap Cost Of Revenue
CostOfRevenue
3697701
CY2024Q2 us-gaap Gross Profit
GrossProfit
-684448
CY2023Q2 us-gaap Gross Profit
GrossProfit
-1431202
us-gaap Gross Profit
GrossProfit
-1447855
us-gaap Gross Profit
GrossProfit
-2173650
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
683381
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1619411
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1449876
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2951716
CY2024Q2 buru Selling And Marketing Expense And Reversal Of Expense
SellingAndMarketingExpenseAndReversalOfExpense
-73070
CY2023Q2 buru Selling And Marketing Expense And Reversal Of Expense
SellingAndMarketingExpenseAndReversalOfExpense
366406
buru Selling And Marketing Expense And Reversal Of Expense
SellingAndMarketingExpenseAndReversalOfExpense
272520
buru Selling And Marketing Expense And Reversal Of Expense
SellingAndMarketingExpenseAndReversalOfExpense
542662
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2111018
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3024013
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5000363
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6074272
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2721329
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
5009830
us-gaap Operating Expenses
OperatingExpenses
6722759
us-gaap Operating Expenses
OperatingExpenses
9568650
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3405777
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6441032
us-gaap Operating Income Loss
OperatingIncomeLoss
-8170614
us-gaap Operating Income Loss
OperatingIncomeLoss
-11742300
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4741
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
12489
us-gaap Investment Income Interest
InvestmentIncomeInterest
16481
us-gaap Investment Income Interest
InvestmentIncomeInterest
44916
CY2024Q2 us-gaap Interest Expense
InterestExpense
941614
CY2023Q2 us-gaap Interest Expense
InterestExpense
12384
us-gaap Interest Expense
InterestExpense
1892481
us-gaap Interest Expense
InterestExpense
12384
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1783201
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-334215
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1786512
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-835539
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10346108
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10346108
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
218169
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
218169
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12687388
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6106712
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18388041
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10874229
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-12687388
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6106712
us-gaap Net Income Loss
NetIncomeLoss
-18388041
us-gaap Net Income Loss
NetIncomeLoss
-10874229
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.60
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.60
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.42
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1670052
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1670052
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
869401
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
869401
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1296478
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1296478
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
754280
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
754280
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8652809
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200000
CY2024Q1 buru Restricted Stock Value Shares Issued Tax Withholdings
RestrictedStockValueSharesIssuedTaxWithholdings
-1873
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
614115
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5700653
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-13541220
CY2024Q2 buru Stock Issued During Period Value Debt Extinguishment
StockIssuedDuringPeriodValueDebtExtinguishment
13356412
CY2024Q2 buru Restricted Stock Value Shares Issued Tax Withholdings
RestrictedStockValueSharesIssuedTaxWithholdings
-70713
CY2024Q2 buru Adjustments To Additional Paid In Capital Pre Funded Warrant Issued
AdjustmentsToAdditionalPaidInCapitalPreFundedWarrantIssued
1539866
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
450572
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-12687388
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-10952471
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1842239
CY2023Q1 buru Issuance Of Common Stock And Series A Preferred Stock Upon Conversion Of Convertible Notes In Connection With The Reverse Recapitalization
IssuanceOfCommonStockAndSeriesAPreferredStockUponConversionOfConvertibleNotesInConnectionWithTheReverseRecapitalization
11575286
CY2023Q1 buru Issuance Of Common Stock And Preferred Stock Upon Reverse Recapitalization Net Of Issuance Costs
IssuanceOfCommonStockAndPreferredStockUponReverseRecapitalizationNetOfIssuanceCosts
-3257525
CY2023Q1 buru Recognition Of Public Warrants Upon The Reverse Recapitalization
RecognitionOfPublicWarrantsUponTheReverseRecapitalization
-1336863
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
463978
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4767517
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
835120
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6999
CY2023Q2 buru Issuance Cost From Issuance Of Common Stock Warrants
IssuanceCostFromIssuanceOfCommonStockWarrants
160345
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2351414
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
796783
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6106712
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-16399
us-gaap Profit Loss
ProfitLoss
-18388041
us-gaap Profit Loss
ProfitLoss
-10874229
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
389538
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
225016
us-gaap Share Based Compensation
ShareBasedCompensation
1064687
us-gaap Share Based Compensation
ShareBasedCompensation
1260761
buru Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
-1786512
buru Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
-835539
buru Inventory Reserve Adjustment
InventoryReserveAdjustment
28012
buru Inventory Reserve Adjustment
InventoryReserveAdjustment
669398
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1531541
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
407120
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10346108
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-409004
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
319735
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
203429
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
160726
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
738424
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
665240
buru Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-188776
buru Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-153138
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
916495
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2639014
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1693890
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-623819
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6400
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1325
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-174592
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-169172
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4322227
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8699808
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
825872
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-825872
buru Proceeds From Issuance Of Senior Convertible Notes And Warrants
ProceedsFromIssuanceOfSeniorConvertibleNotesAndWarrants
9225000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000
buru Proceeds From Issuance Of Prefunded Warrants
ProceedsFromIssuanceOfPrefundedWarrants
1539866
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6999
buru Restricted Stock Units Used For Tax Withholdings
RestrictedStockUnitsUsedForTaxWithholdings
72587
buru Proceeds From Issuance Of Preferred Stock
ProceedsFromIssuanceOfPreferredStock
5000
buru Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
3243079
buru Payment Of Transaction Costs Related To Reverse Recapitalization
PaymentOfTransactionCostsRelatedToReverseRecapitalization
4734913
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4100000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
675000
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
644936
buru Payment Of Deferred Financing Costs
PaymentOfDeferredFinancingCosts
21500
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2290715
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13270162
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2031512
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3744482
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2148700
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2880254
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117188
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6624736
buru Property And Equipment Transferred From Inventory
PropertyAndEquipmentTransferredFromInventory
154971
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
540028
buru Deferred Financing Costs Included In Accounts Payable And Accrued Expenses
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedExpenses
697563
buru Deferred Financing Costs Included In Accounts Payable And Accrued Expenses
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedExpenses
1007439
buru Transaction Costs Related To Reverse Recapitalization Not Yet Paid
TransactionCostsRelatedToReverseRecapitalizationNotYetPaid
1007439
buru Transaction Costs Related To Reverse Recapitalization Not Yet Paid
TransactionCostsRelatedToReverseRecapitalizationNotYetPaid
160345
buru Issuance Of Common Stock Upon Extinguishment Of Debt
IssuanceOfCommonStockUponExtinguishmentOfDebt
13356412
buru Issuance Of Common Stock Upon Conversion Of Preferred Stock In Connection With Reverse Recapitalization
IssuanceOfCommonStockUponConversionOfPreferredStockInConnectionWithReverseRecapitalization
11575286
us-gaap Net Income Loss
NetIncomeLoss
-18388041
us-gaap Net Income Loss
NetIncomeLoss
-10874229
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100286733
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Reclassification</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Certain prior period balances in the consolidated statements of cash flows have been combined or reclassified to conform to current period presentation pursuant to Rule 10-01(a)(2) of Regulation S-X of the SEC. Such reclassifications had no impact on net income, cash flows or shareholders' equity previously reported.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q2 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
76744
us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
76744
CY2024Q2 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
858
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
1256
CY2024Q2 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
54600
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
783098
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
783098
buru Proceeds From Business Combination
ProceedsFromBusinessCombination
3200000
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1922274
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1973634
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
137480
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
158346
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
628117
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
457752
CY2024Q2 us-gaap Inventory Gross
InventoryGross
2687871
CY2023Q4 us-gaap Inventory Gross
InventoryGross
2589732
CY2024Q2 us-gaap Inventory Adjustments
InventoryAdjustments
1161469
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1133457
CY2024Q2 us-gaap Inventory Net
InventoryNet
1526402
CY2023Q4 us-gaap Inventory Net
InventoryNet
1456275
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
154491
us-gaap Inventory Write Down
InventoryWriteDown
28012
us-gaap Inventory Write Down
InventoryWriteDown
385811
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8612856
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8480860
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3269103
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2829884
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5343753
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5650976
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
132643
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
98901
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
389538
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
225016
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
847805
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
61342
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
46868
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
94653
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
6
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
260
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
894679
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
156255
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
415616
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
754904
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2424553
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
838865
CY2024Q2 buru Accrued Transaction Costs Related To Reverse Recapitalization Current
AccruedTransactionCostsRelatedToReverseRecapitalizationCurrent
503600
CY2023Q4 buru Accrued Transaction Costs Related To Reverse Recapitalization Current
AccruedTransactionCostsRelatedToReverseRecapitalizationCurrent
503600
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
160673
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
89346
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
592803
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
337913
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
219400
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
225677
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4316645
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2750305
buru Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
buru Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 buru Stock Price Per Share
StockPricePerShare
11.5
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
0
CY2024Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
0
buru Operating Lease Original Expiry Year And Month
OperatingLeaseOriginalExpiryYearAndMonth
2024-12
buru Operating Lease Extended Expiry Year And Month
OperatingLeaseExtendedExpiryYearAndMonth
2025-06
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
102938
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
85036
us-gaap Operating Lease Cost
OperatingLeaseCost
205876
us-gaap Operating Lease Cost
OperatingLeaseCost
170073
us-gaap Operating Lease Payments
OperatingLeasePayments
191691
us-gaap Operating Lease Payments
OperatingLeasePayments
186107
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
191691
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
240834
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
432525
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14363
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
418162
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
467000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49278
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1054062
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142827
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1524051
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49278
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1054062
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142827
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1524051
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
327200
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
178750
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
482279
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30400
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
73275
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24000
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
30400
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
681279
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
2751533
CY2024Q2 us-gaap Deferred Finance Costs Current Gross
DeferredFinanceCostsCurrentGross
156680
CY2023Q4 us-gaap Deferred Finance Costs Current Gross
DeferredFinanceCostsCurrentGross
600475
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2423274
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2147992
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5385147
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
6713241
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
7808421
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
8861233
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
11400000
CY2023Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.08
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
340
CY2024Q2 buru Stock Issued During Period To Extinguish Debt
StockIssuedDuringPeriodToExtinguishDebt
2248312
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10346108
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10346108
buru Convertible Preferred Stock Textblock
ConvertiblePreferredStockTextblock
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">NOTE 9. CONVERTIBLE PREFERRED STOCK</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Legacy Nuburu Preferred Stock Financing</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">In multiple closings in December 2021 and January 2022, Legacy Nuburu sold an aggregate of </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,166,372</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Legacy Nuburu Series C Preferred Stock, at a purchase price of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.00</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> per share, for an aggregate purchase price of approximately $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Series A Preferred Stock</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Ranking</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Company’s Preferred Stock ranks senior to the Company’s Common Stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dividends</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Holders of the Company’s Preferred Stock participate, on an as-converted basis (without regard to any conversion limitations) in all dividends paid to the holders of the Company’s Common Stock.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Conversion Rights</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Preferred Stock is convertible at any time into Common Stock at a conversion rate equal to $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.25</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> (subject to equitable adjustment in the event of a stock split, stock consolidation, subdivision or certain other events of a similar nature that increase or decrease the number of shares of Preferred Stock outstanding (the “Original Issuance Price”)) divided by the lesser of (i) $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11.50</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> and (ii) the greater of (x) </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">115</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of the lowest volume-weighted average price per share of the Company’s Common Stock as displayed under the heading Bloomberg VWAP (the “VWAP”) for any consecutive ninety-trading day period prior to the calculation of such VWAP and (y) $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.00</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">, in each case subject to adjustment as set forth in the Certificate of Designations (the “Conversion Price”).</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Any conversion will be settled only in shares of Common Stock; provided, that, upon any conversion that would result in the holders beneficially owning greater than </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of the Company’s voting stock outstanding as of the conversion date or any individual holder beneficially owning Common Stock in excess of the maximum number of shares of Common Stock that could be issued to the holder without triggering a change of control under the applicable stock exchange listing rules, the excess, if any, of the conversion consideration otherwise payable upon such conversion shall be paid in cash, based on an amount per share of Common Stock equal to the last reported price per share of the Common Stock on the trading day immediately preceding the conversion date.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Mandatory Conversion</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">If the VWAP is greater than </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">200</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of the Conversion Price for any </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> trading days in a </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">30-day</span></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> trading day period, the Company may elect to convert all, but not less than all, of the Preferred Stock then outstanding into the Company’s Common Stock at a conversion rate with respect to each share of Preferred Stock equal to the Original Issuance Price as of the date of such conversion divided by the then applicable Conversion Price.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Voting Rights</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The holders of Preferred Stock are not entitled to vote at or receive notice of any meeting of stockholders, except the holders of Preferred Stock are entitled to certain consent rights on matters related to (i) the creation or authorization of the creation of any equity or debt securities of the Company that rank senior or equal to certain rights of the Preferred Stock and (ii) the authorization of any adverse change to the powers, preferences, or special rights of the Preferred Stock set forth in the Company’s Certificate of Incorporation or Bylaws, and shall have voting rights as required by law.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Redemption</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">On the second anniversary of the Closing Date, or January 31, 2025 (the “Test Date”), the Company is obligated to redeem the maximum portion of the Preferred Stock permitted by law in cash at an amount equal to the Original Issuance Price as of such date if the Conversion Price exceeds the VWAP. If, on the Test Date, the Conversion Price is equal to or less than the VWAP, the Company must convert all shares of Preferred Stock then outstanding into shares of the Company’s Common Stock at the then applicable Conversion Price. Notwithstanding the foregoing, the Company shall not be required to redeem any shares of Preferred Stock to the extent the Company does not have legally available funds to effect such redemption. The mandatory redemption and conversion provisions described herein are further subject to certain limitations detailed in the Certificate of Designations.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Series A Preferred Stock Issuances</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Company is authorized to issue </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of preferred stock with a par value of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. As of both </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">, there were </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,388,905</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of preferred stock issued and outstanding.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Upon the Closing of the Business Combination, all </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23,237,703</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of issued and outstanding convertible preferred stock were cancelled and converted into </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">580,943</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Legacy Nuburu common stock based upon the conversion rate as calculated pursuant to Legacy Nuburu's Certificate of Incorporation, multiplied by the Exchange Ratios at the Effective Time.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Additionally, upon the Closing of the Business Combination, the cancellation and conversion of all Legacy Nuburu Company Notes into shares of Legacy Nuburu common stock in accordance with its terms as of immediately prior to the Effective Time resulted in the issuance of </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,642,239</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares which were then outstanding as Legacy Nuburu common stock as of immediately prior to the Effective Time and subsequently converted into </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">34,045</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Nuburu Common Stock and </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,361,787</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Nuburu Series A preferred stock at the Effective Time.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">As of the Closing, each Legacy Nuburu stockholder waived its right to participate in the Preferred Stock Issuance (for clarity, excluding any shares received as a result of the conversion of any Legacy Company Notes prior to the Closing, which were entitled to participate in the Preferred Stock Issuance). Legacy Nuburu stockholders were entitled to receive approximately </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">99</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of the Common Stock issued as merger consideration pursuant to the Business Combination Agreement agreed to waive such right by entering into the Stockholder Support Agreement (for clarity, excluding any shares received as a result of the conversion of any Legacy Company Notes). Those Legacy Nuburu stockholders who did not waive their right to participate resulted in the issuance of </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15,478</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Nuburu Series A preferred stock at the Effective Time.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Each Tailwind stockholder who did not redeem their shares received a share of Nuburu Series A preferred stock. This resulted in the issuance of </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">316,188</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Nuburu Series A preferred stock to those non-redeeming stockholders.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Tailwind and the Tailwind Sponsor entered into the Sponsor Support and Forfeiture Agreement. In connection with the Business Combination, the </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8,355,393</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> Founder Shares were forfeited other than </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">28,750</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock (of which, </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,750</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares were transferred to Nautilus Maser Fund, L.P. and </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,250</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares were transferred to Cohen &amp; Company Capital Markets at Closing) and </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">650,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Series A preferred stock.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation (“WSGR”) was engaged by Legacy Nuburu to act as its counsel for the Business Combination. As partial compensation for the services provided by WSGR to Legacy Nuburu in connection with the Business Combination, the Company agreed to issue to WSGR </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,887</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock and </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">195,452</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Preferred Stock pursuant to the terms of the Stock Purchase Agreement entered into by and between the Company and WSGR on March 10, 2023. The foregoing issuance was made in a transaction not involving a public offering pursuant to an exemption from the registration requirements of the Securities Act in reliance upon Section 4(a)(2) of the Securities Act or Regulation D promulgated under the Securities Act.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Legacy Nuburu entered into an engagement letter with Anzu Partners on August 30, 2022 pursuant to which Legacy Nuburu, in recognition of past Services, (i) agreed to pay $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> to Anzu Partners upon the closing of the Business Combination and (ii) issued a warrant with a strike price of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> per share to Anzu Partners for </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Preferred Stock (the “Anzu Partners Warrant”). This warrant was exercised by Anzu Partners in connection with the Closing and the $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> payment was made during 2023.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Conversions</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">In November 2023, a holder of Series A Preferred Stock converted </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">650,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Series A Preferred Stock to </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">32,500</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock under the terms described under "Conversion Rights" above.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q2 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.25
CY2023Q2 buru Adjustments To Additional Paid In Capital Warrant Issued Gross
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedGross
2511759
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
450572
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
796783
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1064687
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1260761
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
188865
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
74.41
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
28971
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.58
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
26697
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
169.02
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
191139
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
50.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
84557
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
79.04
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
191139
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
50.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y4M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.478
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.467
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.034
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
buru Minimum Percentage Increase In Ownership By Five Percent Shareholders During A Three Year Testing Period
MinimumPercentageIncreaseInOwnershipByFivePercentShareholdersDuringAThreeYearTestingPeriod
0.50
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2093088
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2093088
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1344206
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1344206
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
644936

Files In Submission

Name View Source Status
0000950170-24-097169-index-headers.html Edgar Link pending
0000950170-24-097169-index.html Edgar Link pending
0000950170-24-097169.txt Edgar Link pending
0000950170-24-097169-xbrl.zip Edgar Link pending
buru-20240630.htm Edgar Link pending
buru-20240630.xsd Edgar Link pending
buru-ex2_2.htm Edgar Link pending
buru-ex31_1.htm Edgar Link pending
buru-ex31_2.htm Edgar Link pending
buru-ex32_1.htm Edgar Link pending
buru-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
buru-20240630_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable